PMID- 29068869 OWN - NLM STAT- MEDLINE DCOM- 20171103 LR - 20190113 IS - 1536-3678 (Electronic) IS - 1077-4114 (Linking) VI - 39 IP - 8 DP - 2017 Nov TI - Dural Venous Sinus Thrombosis and Pulmonary Embolism Following Immunoglobulin Treatment in Pediatric Patient With Immune Thrombocytopenic Purpura. PG - e508-e511 LID - 10.1097/MPH.0000000000000841 [doi] AB - Intravenous immunoglobulin (IVIG) is a widely used agent as the first choice of treatment of immune thrombocytopenic purpura (ITP). IVIG has several side effects, but it is a relatively safe treatment. Life-threatening thrombosis has been reported in adults and rarely in children. We report a case of a 14-year-old boy with dural venous sinus thrombosis and pulmonary embolism after treatment with IVIG for ITP. The patient was treated with low-molecular-weight heparin followed by warfarin and the symptoms were recovered. If a patient with ITP shows mental change or respiratory difficulty, we should consider thrombosis as well as hemorrhage. FAU - Park, Kyung Mi AU - Park KM AD - Department of Pediatrics, Pusan National University Children's Hospital, Yangsan, Korea. FAU - Yang, Eu Jeen AU - Yang EJ FAU - Lim, Young Tak AU - Lim YT LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Pediatr Hematol Oncol JT - Journal of pediatric hematology/oncology JID - 9505928 RN - 0 (Anticoagulants) RN - 0 (Heparin, Low-Molecular-Weight) RN - 0 (Immunoglobulins, Intravenous) RN - 5Q7ZVV76EI (Warfarin) SB - IM MH - Adolescent MH - Anticoagulants/therapeutic use MH - Biopsy MH - Bone Marrow/pathology MH - Hematologic Tests MH - Heparin, Low-Molecular-Weight/therapeutic use MH - Humans MH - Immunoglobulins, Intravenous/administration & dosage MH - Magnetic Resonance Angiography MH - Male MH - Pulmonary Embolism/*diagnosis/drug therapy/*etiology MH - Purpura, Thrombocytopenic, Idiopathic/*complications/diagnosis/therapy MH - Sinus Thrombosis, Intracranial/*diagnosis/drug therapy/*etiology MH - Tomography, X-Ray Computed MH - Treatment Outcome MH - Venous Thrombosis/diagnosis/etiology MH - Warfarin/therapeutic use EDAT- 2017/10/27 06:00 MHDA- 2017/11/04 06:00 CRDT- 2017/10/26 06:00 PHST- 2017/10/26 06:00 [entrez] PHST- 2017/10/27 06:00 [pubmed] PHST- 2017/11/04 06:00 [medline] AID - 00043426-201711000-00039 [pii] AID - 10.1097/MPH.0000000000000841 [doi] PST - ppublish SO - J Pediatr Hematol Oncol. 2017 Nov;39(8):e508-e511. doi: 10.1097/MPH.0000000000000841.